About Us
About Us
Leadership
Leadership
Careers
Our Science
Partnering
News
Contact
Contact
Contact
News
Filter by:
view all
press
media
publication
conference
conference
Apr 23, 2023
2023 - AACR - SQ3370 Poster
SQ3370, a doxorubicin-based click chemistry therapeutic, promotes a shift from an immunosuppressive towards a T-cell permissive tumor microenvironment in patients
conference
Apr 23, 2023
2023 - AACR - SQP22 Poster
A click chemistry-activated auristatin protodrug (SQP22) demonstrates potency and safety with antibody and intratumoral tumor-targeting agents
conference
Apr 16, 2023
2023 AACR
CAPAC a modular platform that can improve the safety and efficacy of existing cancer therapies
media
Apr 1, 2023
Drug Discovery World
The Nobel Prize winning power of click chemistry
publication
Mar 29, 2023
Pre print
SQ3370, the first clinical click chemistry-activated cancer therapeutic, shows safety in humans and translatability across species
media
Mar 1, 2023
Pharma's Almanac
What do you view as the most disruptive or transformational technology or development on the horizon?
media
Mar 1, 2023
Life Science Leader
Translating Nobel Prize Winning Science Into Medicine
media
Feb 8, 2023
The Bio Report
A Company That Bets Its Therapies Will Click with Patients
media
Jan 12, 2023
Healio
Nobel laureate takes pride in success of bioorthogonal chemistry for cancer treatment
media
Dec 2, 2022
SF Business Times
The Long Game, Nobel Prize winners pay it forward
conference
Nov 7, 2022
2022 - SITC - SQ3370 Poster
Treatment with SQ3370, a doxorubicin-based click chemistry therapeutic, promotes immune activation in the tumor microenvironment
conference
Nov 7, 2022
2022 - SITC - SQ2270 Poster
SQ2270, a Novel MMAE-based Click Chemistry Therapeutic, Promotes Tumor Growth Inhibition and Extensive Immune Cell Infiltration in the RENCA Cancer Model
Previous
2 / 8
Next